Results 171 to 180 of about 1,626 (189)

Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting

Drugs of Today, 2002
Ramosetron is a selective serotonin 5-HT3 receptor antagonist with an affinity higher than that of the previously available drugs ondansetron, granisetron and tropisetron. Ramosetron was shown in pharmacological assays to inhibit activities mediated by 5-HT3 receptors, such as emesis caused by cisplatin.
openaire   +2 more sources

Ramosetron vs. ramosetron plus dexamethasone on the PONV after laparoscopic cholecystectomy

European Journal of Anaesthesiology, 2012
J.-H. Ryu, H.-M. Sohn, S.-J. Park, S.-H. Do   +3 more
openaire   +1 more source

Ramosetron Is Effective in Women With IBS-D

MD Conference Express, 2015
L. Lederman, S. Fukudo
openaire   +1 more source

Comparitive Study of Intravenous Ramosetron and Ramosetron with Dexamethasone as Prophylactic Anti-PONV in Patients Coming for Elective ENT Surgeries

Indian Journal of Anesthesia and Analgesia, 2017
Amitha S., Yoganarasimha N
openaire   +1 more source

Anterior Resection Syndrome: A Randomized Clinical Trial of a 5-HT3 Receptor Antagonist (Ramosetron) in Male Patients With Rectal Cancer.

British Journal of Surgery, 2021
S H Moon, K J Park, M A Lee
exaly  

Ramosetron approved in Japan.

Inpharma Weekly, 2008
openaire   +1 more source

Ramosetron

Reactions Weekly
openaire   +1 more source

Ramosetron OD Tablet and Postdischarge Nausea and Vomiting

Case Medical Research, 2020
openaire   +1 more source

Ramosetron + dexamethasone settles the stomach after cisplatin

Reactions Weekly, 2005
openaire   +2 more sources

Comparative Study of [3H]Ramosetron and [3H]Granisetron Binding in the Cloned Human 5-Hydroxytryptamine3 Receptors

The Japanese Journal of Pharmacology, 1998
Tokio Yamaguchi, S Akuzawa, Shinobu Akuzawa   +2 more
exaly